Fact sheet: Woodford PatientCapTrt

Fund information
Fund name
Woodford Patient Capital Trust PLC ORD 1P
Fund manager company
Woodford Investment Management
Fund type
Investment Trust
Fund manager
  • Neil Woodfordsince 20/04/2015
Fund objective
To achieve long-term capital growth through investing in a portfolio consisting predominantly of UK companies, both quoted and unquoted. The Company will aim to deliver a return in excess of 10% per annum over the longer term.
Benchmark
No data available.
Investment style
Growth
Investment method
Shares
Quick stats
1 Year return
-3.2%
1 Year rank in sector
14/15
Sector
IT UK All Companies
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
0.1%
Fund size
£787m
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
139
Mid price
95.2
NAV
?Net asset value. The NAV per share may be higher or lower than the share price, which in turn is trading at either a discount or a premium to NAV.
100.22
Discount/Premium
?When the market price of an investment trust’s shares is less than the net asset value (NAV) per share then it is trading at a discount to NAV. A trust’s shares are on a premium when they trade at a higher price than the NAV.
-5.01
Gearing
?Investment trusts have the ability to borrow money which they invest with the aim of generating a higher return than the cost of the loan. An ungeared trust has a figure of 100. A figure of 110 would represent a trust with 10% gearing.
100
Top in this sector
Fund name1 Year
Manchester & London IT plc37.4%
Aurora Investment Trust plc25.1%
Fidelity Special Values PLC22.9%
Artemis Alpha Tst plc21.9%
Mrtl IT PLC20.5%
...more in IT UK All Companies

Performance snapshot

Holdings snapshot

  • UK80.9%
    USA24.2%
    Norway3.8%
    Ireland2.1%
    Switzerland1%
  • Health Care66.3%
    Financials31.7%
    Technology6.9%
    Industrials6.8%
    Telecommunications2.6%
  • UK Equities80.9%
    US Equities24.2%
    Norwegian Equities3.8%
    Irish Equities2.1%
    Swiss Equities1%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund-3.8%2.8%1.6%-3.2%--
Sector-0.7%-0.1%2%14.1%25.1%76.1%
Rank within sector14 / 155 / 158 / 1514 / 15--
Quartile4th2nd3rd4th
Calendar performance
 YTD - 20172016201520142013
Fund4.6%-9.7%---
Sector11.4%3.8%9.1%-1.7%31.3%
Rank within sector12 / 1514 / 15---
Quartile4th4th
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
-
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
-
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
-
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
-
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
-
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
-
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
-
Price movement
52 week high106
52 week low87.4
Current bid price95.15
Current offer price95.65
Current mid price95.2
Region
1UK80.85%
2USA24.22%
3Norway3.78%
4Ireland2.11%
5Switzerland0.96%
6Luxembourg0.55%
7Money Market-12.47%
Industry sector
1Health Care66.27%
2Financials31.68%
3Technology6.9%
4Industrials6.84%
5Telecommunications2.59%
6Consumer Goods2.04%
7Basic Materials0.28%
8Money Market-16.6%
Asset type
1UK Equities80.85%
2US Equities24.22%
3Norwegian Equities3.78%
4Irish Equities2.11%
5Swiss Equities0.96%
6Luxembourg Equities0.55%
7Money Market-12.47%
Individual holdings
1PROTHENA CORP PLC16.2%
2PURPLEBRICKS GROUP PLC11.8%
3OXFORD NANOPORE8.47%
4IMMUNOCORE A7.21%
5THERAVANCE BIOPHARMA INC4.24%
6PROTON PARTNERS INTERNATIONAL4.05%
7MEREO BIOPHARMA GROUP LTD3.92%
8OXFORD SCIENCES INNOVATION3.24%
9ATOM BANK (UNQUOTED)2.77%
Management
Fund manager group
No data available.
Fund manager company
Woodford Investment Management
Fund type
Investment Trust
Fund objective
To achieve long-term capital growth through investing in a portfolio consisting predominantly of UK companies, both quoted and unquoted. The Company will aim to deliver a return in excess of 10% per annum over the longer term.
Benchmark
No data available.
Investment style
Growth
Investment method
Shares
Fund manager
NameSinceBiography
Neil Woodford20/04/2015Neil began his career with the Dominion Insurance Company having graduated with a degree in Economics and Agricultural Economics from the University of Exeter in 1981. He pursued postgraduate studies in Finance at the London Business School during the mid-1980s before joining Eagle Star as a fund manager in 1987. In 1988, Neil moved to Henley-based fund manager Perpetual (now Invesco Perpetual), where he forged a formidable reputation running two of the UK’s biggest and most successful retail funds – Invesco Perpetual Income and Invesco Perpetual High Income. In April 2014, Neil left Invesco Perpetual to set up Woodford Investment Management LLP, where he is Head of Investment. He is the lead fund manager on the firm’s flagship retail fund the £8.54bn CF Woodford Equity Income fund, which raised a record £1.6bn during a two-and-a-half week launch offer period in June 2014. He also manages Woodford Patient Capital Trust, the £800m investment trust launched in April 2015 that invests predominantly in early-stage and early-growth businesses. Neil was appointed Commander of the Order of the British Empire (CBE) for services to the economy in the 2013 Queen’s Birthday Honours.
Compliance
AIC Member
Domicile
No data available.
Fund for sale in
United Kingdom
Woodford Patient Capital Trust PLC ORD 1P
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price100.22
CurrencyGBX
Price updated14/09/2017
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeNJDP
Woodford Patient Capital Trust PLC ORD 1P NAV
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price0.9983
CurrencyGBP
Price updated13/09/2017
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeNYJA
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.